Johannes Gutenberg-Universität Mainz
- 6131/39-0
Rutz, Jochen; Maxeiner, Sebastian; Grein, Timothy et al.
Allyl-, Butyl- and Phenylethyl-Isothiocyanate Modulate Akt-mTOR and Cyclin-CDK Signaling in Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell LinesINTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Bd. 23. H. 19. 2022
Miederer, Matthias
Alpha emitting nuclides in nuclear medicine theranosticsNUKLEARMEDIZIN-NUCLEAR MEDICINE. Bd. 61. H. 03. 2022 S. 273-279
Hennermann, Julia B.
Alpha-mannosidosis: a rare but underdiagnosed disease?MONATSSCHRIFT KINDERHEILKUNDE. 2022
Reinwarth, AC; Beutel, ME; Brähler, E
Alter und Altern in der PsychosomatikPPmP-Psychotherapie· Psychosomatik· Medizinische Psychologie. Bd. 72. H. 03/04. 2022 S. 105-107
Vilar, Juliana B.; Christmann, Markus; Tomicic, Maja T.
Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?CANCERS. Bd. 14. H. 10. 2022
Hampel, Ulrike; Elflein, Heike M.; Kakkassery, V. et al.
Alterations of the anterior segment of the eye caused by exposure to UV radiationOPHTHALMOLOGIE. Bd. 119. H. 3. 2022 S. 234-239
Ciolac, Dumitru; Gonzalez-Escamilla, Gabriel; Winter, Yaroslav et al.
Altered grey matter integrity and network vulnerability relate to epilepsy occurrence in patients with multiple sclerosisEUROPEAN JOURNAL OF NEUROLOGY. Bd. 29. H. 8. 2022 S. 2309-2320
Schmidt-Kraepelin, Christian; Feyerabend, Sandra; Engelke, Christina et al.
Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trialLANCET PSYCHIATRY. Bd. 9. H. 4. 2022 S. 291-306
Mezger, Kerstin; Ebert, Sabine; Muhle, Hannah Elisa et al.
Amsacrine combined with etoposide and methylprednisolone is a feasible and safe component in first-line intensified treatment of pediatric patients with high-risk acute lymphoblastic leukemia in CoALL08-09 trialPEDIATRIC BLOOD & CANCER. Bd. 69. H. 12. 2022
Tsaur, Igor; Thomas, Anita; Monecke, Michelle et al.
Amygdalin Exerts Antitumor Activity in Taxane-Resistant Prostate Cancer CellsCANCERS. Bd. 14. H. 13. 2022